We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+2.22%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$121M
AUM Growth
-$4.02M
Cap. Flow
-$6.69M
Cap. Flow %
-5.54%
Top 10 Hldgs %
48.15%
Holding
84
New
10
Increased
18
Reduced
47
Closed
7

Top Buys

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$1.62M
2
GILD icon
Gilead Sciences
GILD
+$1.35M
3
INSM icon
Insmed
INSM
+$1.3M
4
BMY icon
Bristol-Myers Squibb
BMY
+$1.23M
5
MDT icon
Medtronic
MDT
+$1.06M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$1.4M
2
AMGN icon
Amgen
AMGN
+$1.38M
3
ABBV icon
AbbVie
ABBV
+$1.02M
4
CTNM
Contineum Therapeutics
CTNM
+$982K
5
LLY icon
Eli Lilly
LLY
+$935K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVMD icon
76
Revolution Medicines
RVMD
$39.6B
$202K 0.17%
+1,830
New +$185K
PALI icon
77
Palisade Bio
PALI
$342M
$172K 0.14%
+88,000
New +$160K
AZN icon
78
AstraZeneca
AZN
$262B
-7,616
Closed -$1.4M
FOLD
79
DELISTED
Amicus Therapeutics
FOLD
-43,300
Closed -$617K
MDGL icon
80
Madrigal Pharmaceuticals
MDGL
$12.8B
-352
Closed -$205K
VTYX
81
DELISTED
Ventyx Biosciences
VTYX
-96,945
Closed -$875K
LENZ
82
LENZ Therapeutics
LENZ
$162M
-42,500
Closed -$680K
TEM
83
Tempus AI
TEM
$9.42B
-4,500
Closed -$266K
CARL
84
Carlsmed
CARL
$317M
-47,700
Closed -$589K

Similar funds

Sectoral Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Sectoral Asset Management held 84 positions worth $121M, down 3.2% from $125M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Sectoral Asset Management withdrew a net $6.69M in Q1 2026, closing 7 positions and reducing 47 holdings. Its most notable exit was AstraZeneca, an estimated $1.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Sectoral Asset Management opened a new position in IQVIA worth $1.42M.

  • Sectoral Asset Management's largest Q1 2026 buy was IQVIA: 8,307 shares worth $1.42M.
  • Sectoral Asset Management added most to Gilead Sciences in Q1 2026, an estimated $1.35M increase.
  • Sectoral Asset Management's biggest Q1 2026 reduction was Amgen, cutting an estimated $1.38M.
  • Sectoral Asset Management fully exited AstraZeneca in Q1 2026, selling an estimated $1.4M.
  • Sectoral Asset Management's ten largest holdings make up 48% of its $121M portfolio in Q1 2026.
  • Sectoral Asset Management opened 10 new positions and closed 7 in Q1 2026.
  • Sectoral Asset Management's portfolio value fell 3.2% quarter-over-quarter to $121M.

Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.